江苏快三免费计划软件

  • <tr id="CZ4anK"><strong id="CZ4anK"></strong><small id="CZ4anK"></small><button id="CZ4anK"></button><li id="CZ4anK"><noscript id="CZ4anK"><big id="CZ4anK"></big><dt id="CZ4anK"></dt></noscript></li></tr><ol id="CZ4anK"><option id="CZ4anK"><table id="CZ4anK"><blockquote id="CZ4anK"><tbody id="CZ4anK"></tbody></blockquote></table></option></ol><u id="CZ4anK"></u><kbd id="CZ4anK"><kbd id="CZ4anK"></kbd></kbd>

    <code id="CZ4anK"><strong id="CZ4anK"></strong></code>

    <fieldset id="CZ4anK"></fieldset>
          <span id="CZ4anK"></span>

              <ins id="CZ4anK"></ins>
              <acronym id="CZ4anK"><em id="CZ4anK"></em><td id="CZ4anK"><div id="CZ4anK"></div></td></acronym><address id="CZ4anK"><big id="CZ4anK"><big id="CZ4anK"></big><legend id="CZ4anK"></legend></big></address>

              <i id="CZ4anK"><div id="CZ4anK"><ins id="CZ4anK"></ins></div></i>
              <i id="CZ4anK"></i>
            1. <dl id="CZ4anK"></dl>
              1. <blockquote id="CZ4anK"><q id="CZ4anK"><noscript id="CZ4anK"></noscript><dt id="CZ4anK"></dt></q></blockquote><noframes id="CZ4anK"><i id="CZ4anK"></i>
                Academics Activity

                A Scientific Research Result Published in the Subsidiary Journal of Nature

                Article author:
                DateandTime:2020-08-21
                pageviews:

                On July 21, 2020, Nature’s “Scientific Reports” published the research result “Selection of mutant µplasmin for amyloid-β cleavage in vivo” by Dr. Yang Dongying from the School of Medicine and Nursing of our school as the first author.

                This technology is one of the core technologies of protein drug research and development, which opens up a feasible way for the development of special protein drugs. Based on the research and development of this technology, our school has actively carried out scientific and technological services in fungal research, animal experimental research on the sequel of pulmonary fibrosis after the new coronavirus, and received support from relevant drug research and development companies, and so far, received research funding of 500,000 yuan.